Rhodiola rosea: A Quantitative and Qualitative Assessment of Global Publications Output during 2003-18

Abstract

A quantitative and qualitative assessment of global research output (2016) on the “Rhodiola rosea” plant based on select bibliometric indicators, using Scopus database covering period 1993-2018, is presented here. Analyzed data on a series of bibliometric measures, like average annual growth, citations per paper, international collaborative papers, relative citation index, activity index, top productive countries, organizations, authors, journals and highly cited papers. The global publications registered an annual average growth rate of 12.97% and its citation impact averaged to 17.59 citations per paper. China and USA together account for more than 36% share of global output on Rhodiola rosea, whereas other 8 top ranking countries accounted each for global share between 4.06% and 7.60% during 2003-18. 83.04% global publication share and 89.95% global citation share has been contributed by top 10 countries during 2003-18. Sweden (2.78), Canada (1.17) and USA (1.11) registered the highest relative citation index among top 10 countries during 2003-81. Swedish Herbal Institute, Askloster, Sweden (21 papers), Medical University of Warsaw, Poland (14 papers), Corvinus University of Budapest, Hungary were the three the most productive organizations and Z. Gyorgy and A. Panossian (18 papers each) and G. Wikman (14 papers) were the three top most productive authors. Phytomedicine (25 papers), Phytotherapy Research (21 papers) and Evidence-based Complementary and Alternate Medicine (15 papers) were the three leading journals contributing research in this area.